首页> 外文期刊>Obstetrical and gynecological survey >Dehydroepiandrosterone Replacement in Women With Adrenal Insufficiency
【24h】

Dehydroepiandrosterone Replacement in Women With Adrenal Insufficiency

机译:肾上腺皮质功能减退症女性的脱氢表雄酮替代治疗

获取原文
获取外文期刊封面目录资料

摘要

Because it seemed logical to clarify the role of dehydroepiandrosterone (DHEA) in patients with adrenal insufficiency, 24 affected women were randomly assigned, in a double-blind study, to receive either 50 mg of DHEA or a placebo by mouth each morning for 4 months, with a crossover after a 1-month washout period. Fourteen women had primary adrenal insufficiency, most often as a result of autoimmune adrenalitis. Surgery was the most common cause of secondary adrenal insufficiency. Serum hormone levels were estimated, patient well-being was assessed using psychological questionnaires, and sexual function was assessed using visual analogue scales. Participants were evaluated before and after 1 and 4 months of treatment and again 1 month after the final treatment.Serum levels of DHEA, DHEA sulfate, and androstenedione rose to normal during active treatment. Serum testosterone and dihydrotestosterone increased to the low-normal range, whereas estrone and estradiol levels did not change significantly. Sex hormone–binding globulin levels were significantly lower after 4 months on DHEA than after placebo. Serum levels of insulin-like growth factor I increased significantly only in women with primary adrenal insufficiency. Serum levels of total and high-density lipoprotein cholesterol fell significantly during DHEA treatment. DHEA but not placebo significantly reduced scores for depression, anxiety, hostility, and obsessive-compulsive traits and was associated with higher levels of general well-being. Women given DHEA had more sexual thoughts and interest and were more satisfied with both the mental and physical aspects of their sexuality. Five women had androgenic side effects from DHEA, and a large majority had some skin-related effects by the end of the study; most, however, were mild and transient. Three women had a slight temporary rise in serum aminotransferase.These findings suggest that DHEA should be a part of any hormone replacement regimen in women with adrenal insufficiency. It will be of interest to learn whether it also has beneficial effects in men.N Engl J Med 1999;341:1013–1020
机译:由于阐明脱氢表雄酮 (DHEA) 在肾上腺皮质功能不全患者中的作用似乎是合乎逻辑的,因此在一项双盲研究中,24 名受影响的女性被随机分配,每天早上口服 50 毫克 DHEA 或安慰剂,持续 4 个月,并在 1 个月的清除期后交叉。14名妇女患有原发性肾上腺皮质功能不全,最常见的原因是自身免疫性肾上腺炎。手术是继发性肾上腺皮质功能减退的最常见原因。估计血清激素水平,使用心理问卷评估患者的健康状况,并使用视觉模拟量表评估性功能。在治疗前后 1 个月和 4 个月以及最后一次治疗后 1 个月再次对参与者进行评估。在积极治疗期间,血清 DHEA、DHEA 硫酸盐和雄烯二酮水平升高至正常水平。血清睾酮和二氢睾酮升高至正常低范围,而雌酮和雌二醇水平无显著变化。服用 DHEA 4 个月后,性激素结合球蛋白水平明显低于安慰剂后。胰岛素样生长因子I的血清水平仅在原发性肾上腺皮质功能减退症女性中显著增加。在DHEA治疗期间,血清总胆固醇和高密度脂蛋白胆固醇水平显著下降。DHEA 而非安慰剂显着降低了抑郁、焦虑、敌意和强迫症特质的得分,并且与更高水平的总体幸福感相关。接受DHEA的女性有更多的性想法和兴趣,并且对性行为的精神和身体方面都更满意。五名女性有DHEA的雄激素副作用,绝大多数在研究结束时有一些与皮肤相关的影响;然而,大多数是轻微和短暂的。三名女性的血清转氨酶略有暂时升高。这些发现表明,DHEA 应成为肾上腺皮质功能减退症女性任何激素替代方案的一部分。了解它是否对男性也有有益作用将很有趣。N Engl J Med 1999;341&冒号;1013–1020

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号